|
31 |
Access with Evidence Development in the UK Enthalten in PharmacoEconomics Bd. 28, 23.9.2012, Nr. 2, date:2.2010: 163-170
|
|
|
32 |
Achieving Remission as a Routine Goal of Pharmacotherapy in Attention-Deficit Hyperactivity Disorder Enthalten in CNS drugs Bd. 25, 29.8.2012, Nr. 1, date:1.2011: 17-36
|
|
|
33 |
Acknowledgement Enthalten in Clinical drug investigation Bd. 30, 24.8.2012, Nr. 12, date:12.2010: 805-810
|
|
|
34 |
Acknowledgement Enthalten in Sports medicine Bd. 39, 1.12.2009, Nr. 12, date:12.2009: 977-979
|
|
|
35 |
Acknowledgement Enthalten in PharmacoEconomics Bd. 30, 23.12.2012, Nr. 12, date:12.2012: 1097-1099
|
|
|
36 |
Acknowledgment Enthalten in Drugs in R & D Bd. 10, 25.11.2012, Nr. 4, date:11.2010: 211-212
|
|
|
37 |
Acknowledgment Enthalten in Drugs in R & D Bd. 11, 27.11.2012, Nr. 4, date:12.2011: 289-290
|
|
|
38 |
Acute Bacterial Meningitis in Infants and Children Enthalten in Pediatric drugs Bd. 13, 31.8.2012, Nr. 6, date:12.2011: 385-400
|
|
|
39 |
Acute Exercise and Subsequent Nutritional Adaptations Enthalten in Sports medicine Bd. 42, 23.12.2012, Nr. 7, date:7.2012: 607-613
|
|
|
40 |
Acute Severe Asthma Enthalten in Drugs Bd. 69, 17.9.2012, Nr. 17, date:12.2009: 2363-2391
|
|